Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00538694
Recruitment Status : Completed
First Posted : October 3, 2007
Last Update Posted : July 17, 2015
Information provided by:
Cubist Pharmaceuticals LLC

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2001
  Actual Study Completion Date : September 2001